Nucleoporins in Cancer: Functional Roles and Therapeutic Opportunities. [PDF]
Kirthika P +4 more
europepmc +1 more source
Pathologies at the gateway: exploring the link between nucleoporins and inherited diseases. [PDF]
Braun DA +3 more
europepmc +1 more source
Phosphate-dependent nuclear export via a non-classical NES class recognized by exportin Msn5. [PDF]
Fung HYJ +8 more
europepmc +1 more source
Nuclear PD-L1: an emerging oncogenic driver and promising therapeutic target in cancer. [PDF]
Guo C +5 more
europepmc +1 more source
Integrative mapping reveals molecular features underlying the mechanism of nucleocytoplasmic transport. [PDF]
Raveh B +11 more
europepmc +1 more source
Spindle morphology changes between meiosis and mitosis driven by CK2 regulation of the Ran pathway. [PDF]
Cantwell H +3 more
europepmc +1 more source
Nap1 and Kap114 co-chaperone H2A-H2B and facilitate targeted histone release in the nucleus. [PDF]
Fung HYJ +4 more
europepmc +1 more source
Nuclear β-catenin: molecular regulation, challenges and therapeutic opportunities. [PDF]
Xie B +5 more
europepmc +1 more source
Small molecule JRMS modulating importin-β1 chaperone activity as a therapeutic strategy reducing TDP-43 pathology. [PDF]
Shenouda M +5 more
europepmc +1 more source
Drug Discovery of Allosteric Molecular Glue Degraders (aMGDs): Expanding the Landscape of Targeted Protein Degradation. [PDF]
Xue Y, Ali S, Chen H, Zhou J.
europepmc +1 more source

